Nephros Stock Fundamentals
| NEPH Stock | USD 1.63 0.01 0.62% |
Nephros fundamentals help investors to digest information that contributes to Nephros' financial success or failures. It also enables traders to predict the movement of Nephros Stock. The fundamental analysis module provides a way to measure Nephros' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nephros stock.
As of now, Nephros' EBIT is increasing as compared to previous years. The Nephros' current Research Development is estimated to increase to about 1.5 M, while Depreciation And Amortization is projected to decrease to under 128.2 K. Nephros | Select Account or Indicator |
Nephros Company Return On Equity Analysis
Nephros' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nephros Return On Equity | 0.0087 |
Most of Nephros' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nephros is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Nephros Preferred Stock Total Equity
Preferred Stock Total Equity |
|
Based on the latest financial disclosure, Nephros has a Return On Equity of 0.0087. This is 100.04% lower than that of the Household Durables sector and 100.15% lower than that of the Consumer Discretionary industry. The return on equity for all United States stocks is 102.81% lower than that of the firm.
Nephros Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nephros's current stock value. Our valuation model uses many indicators to compare Nephros value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nephros competition to find correlations between indicators driving Nephros's intrinsic value. More Info.Nephros is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.03 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Nephros is roughly 29.00 . As of now, Nephros' Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nephros' earnings, one of the primary drivers of an investment's value.Nephros Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nephros' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nephros could also be used in its relative valuation, which is a method of valuing Nephros by comparing valuation metrics of similar companies.Nephros is currently under evaluation in return on equity category among its peers.
Nephros Current Valuation Drivers
We derive many important indicators used in calculating different scores of Nephros from analyzing Nephros' financial statements. These drivers represent accounts that assess Nephros' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nephros' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 75.0M | 77.9M | 11.9M | 35.9M | 15.5M | 19.7M | |
| Enterprise Value | 73.4M | 71.8M | 9.4M | 33.5M | 30.1M | 18.9M |
Nephros Fundamentals
| Return On Equity | 0.0087 | ||||
| Return On Asset | 3.0E-4 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 14.84 M | ||||
| Shares Outstanding | 10.54 M | ||||
| Shares Owned By Insiders | 12.86 % | ||||
| Shares Owned By Institutions | 44.69 % | ||||
| Number Of Shares Shorted | 9.57 K | ||||
| Price To Earning | (4.51) X | ||||
| Price To Book | 2.00 X | ||||
| Price To Sales | 1.21 X | ||||
| Revenue | 14.16 M | ||||
| Gross Profit | 8.72 M | ||||
| EBITDA | 193 K | ||||
| Net Income | (1.57 M) | ||||
| Cash And Equivalents | 4.18 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 1.84 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.27 X | ||||
| Book Value Per Share | 0.81 X | ||||
| Cash Flow From Operations | 827 K | ||||
| Short Ratio | 0.44 X | ||||
| Earnings Per Share | 0.01 X | ||||
| Target Price | 4.75 | ||||
| Beta | 1.2 | ||||
| Market Capitalization | 17.19 M | ||||
| Total Asset | 11.86 M | ||||
| Retained Earnings | (144.41 M) | ||||
| Working Capital | 6.29 M | ||||
| Current Asset | 1.53 M | ||||
| Current Liabilities | 684 K | ||||
| Net Asset | 11.86 M |
About Nephros Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nephros's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nephros using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nephros based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -1.1 M | -1.1 M | |
| Total Revenue | 14.2 M | 14.9 M | |
| Cost Of Revenue | 5.4 M | 5.7 M | |
| Sales General And Administrative To Revenue | 0.91 | 0.87 | |
| Research And Ddevelopement To Revenue | 0.06 | 0.06 | |
| Revenue Per Share | 1.35 | 1.28 | |
| Stock Based Compensation To Revenue | 0.09 | 0.08 | |
| Capex To Revenue | 0.01 | 0.01 |
Currently Active Assets on Macroaxis
When determining whether Nephros offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nephros' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nephros Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nephros Stock:Check out Nephros Piotroski F Score and Nephros Altman Z Score analysis. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Household Appliances space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.01 | Revenue Per Share | Quarterly Revenue Growth 0.189 | Return On Assets | Return On Equity |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.